Literature DB >> 8203569

Myocardial relaxant effect of exogenous nitric oxide in isolated ejecting hearts.

R Grocott-Mason1, S Fort, M J Lewis, A M Shah.   

Abstract

In isolated myocytes and papillary muscles, both nitric oxide, acting through guanosine 3',5'-cyclic monophosphate (cGMP), and cGMP analogues exert a novel effect on myocardial contraction, influencing mainly the onset of relaxation. We studied the effect of the exogenous nitric oxide donor, sodium nitroprusside (0.1-10 microM), in isolated ejecting guinea pig hearts at constant filling pressure, afterload, and heart rate to identify its direct myocardial effects in the whole heart. Sodium nitroprusside induced concentration-dependent increases in coronary flow as well as premature and faster early left ventricular (LV) pressure decline, but did not change end-diastolic or peak LV pressure or peak rate of rise of LV pressure. There was no correlation between changes in coronary flow and LV pressure decline. Sodium nitroprusside effects were inhibited by hemoglobin, which inactivates nitric oxide. The cGMP-independent vasodilator nicardipine also increased coronary flow but did not influence early LV pressure fall. Thus exogenous nitric oxide exerts novel direct myocardial relaxant effects in the isolated ejecting heart, independent of its known vasodilator activity, and without compromising systolic function.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8203569     DOI: 10.1152/ajpheart.1994.266.5.H1699

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  18 in total

Review 1.  The nitric oxide pathway in the cardiovascular system.

Authors:  S Llorens; J Jordán; E Nava
Journal:  J Physiol Biochem       Date:  2002-09       Impact factor: 4.158

2.  Inhibition of nitric oxide synthase augments the positive inotropic effect of nitric oxide donors in the rat heart.

Authors:  G Müller-Strahl; K Kottenberg; H G Zimmer; E Noack; G Kojda
Journal:  J Physiol       Date:  2000-01-15       Impact factor: 5.182

3.  Deficiency in myocardial NO biosignalling after cardioplegic arrest: mechanisms and contribution to post-storage mechanical dysfunction.

Authors:  C Rach; M Gandhi; J Docherty; B A Finegan; A S Clanachan
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

Review 4.  Beneficial effects of nitric oxide on cardiac diastolic function: 'the flip side of the coin'.

Authors:  W J Paulus
Journal:  Heart Fail Rev       Date:  2000-12       Impact factor: 4.214

Review 5.  Diastolic ventricular interaction and ventricular diastolic filling.

Authors:  J A Morris-Thurgood; M P Frenneaux
Journal:  Heart Fail Rev       Date:  2000-12       Impact factor: 4.214

Review 6.  Myocardial contractile effects of nitric oxide.

Authors:  Walter J Paulus; Jean G F Bronzwaer
Journal:  Heart Fail Rev       Date:  2002-10       Impact factor: 4.214

7.  Nitric oxide inhibits creatine kinase and regulates rat heart contractile reserve.

Authors:  W L Gross; M I Bak; J S Ingwall; M A Arstall; T W Smith; J L Balligand; R A Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

8.  Acute cardiac and hemodynamic effects of sildenafil on resistant hypertension.

Authors:  Thiago Quinaglia; Ana Paula C de Faria; Vanessa Fontana; Natália R Barbaro; Andréa R Sabbatini; Jonas T Sertório; Caroline Demacq; José E Tanus-Santos; Heitor Moreno
Journal:  Eur J Clin Pharmacol       Date:  2013-08-21       Impact factor: 2.953

9.  Myocardial and coronary endothelial protective effects of acetylcholine after myocardial ischaemia and reperfusion in rats: role of nitric oxide.

Authors:  V Richard; T Blanc; N Kaeffer; C Tron; C Thuillez
Journal:  Br J Pharmacol       Date:  1995-08       Impact factor: 8.739

10.  Nitroglycerin-induced direct protection of the ischaemic myocardium in isolated working hearts of rats with vascular tolerance to nitroglycerin.

Authors:  P Ferdinandy; Z Szilvássy; T Csont; C Csonka; E Nagy; M Koltai; L Dux
Journal:  Br J Pharmacol       Date:  1995-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.